A wonderful breakthrough for sufferers of MS.
40% of patients in the seven-year clinical trial experienced a reversal of symptoms.
Multiple Sclerosis (MS) is a neurodegenerative disease that results in victims slowly losing their ability to speak, walk, and see. For obvious reasons, scientists have been working tirelessly for decades to find a solution to the health illness. And now, it seems potential remedy has been discovered.
According to a new study, published in The Lancet, a combination treatment of both chemotherapy and stem cell therapy may be the solution sought to remedy MS. Over a period of seven years, researchers conducted a clinical trial and witnessed a significant reversal of the effects of aggressive relapsing MS in 24 patients.
The Telegraph reports that the therapy, which is normally reserved for leukemia patients, involves giving patients a medication that forces the stem cells inside their bone marrow to enter the bloodstream. From there, the cells can be harvested, purified, and frozen. Next, the patient’s immune system is completely eradicated with chemo. Then, the patient has their frozen stem cells transplanted back into their bone marrow with the hope of giving them a fresh immune system.